Rockefeller Capital Management L.P. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 58 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2022$27,000
+250.0%
0.00%
Q3 2022$02,0000.0%0.00%
Q2 2022$0
-100.0%
2,0000.0%0.00%
Q1 2022$2,0000.0%2,0000.0%0.00%
Q4 2021$2,000
-50.0%
2,0000.0%0.00%
Q3 2021$4,000
+33.3%
2,0000.0%0.00%
Q2 2021$3,000
-25.0%
2,0000.0%0.00%
Q1 2021$4,0000.0%2,0000.0%0.00%
Q4 2020$4,0000.0%2,0000.0%0.00%
Q3 2020$4,0002,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders